A detailed history of Ht Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ht Partners LLC holds 2,741 shares of ABBV stock, worth $456,431. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,741
Previous 2,876 4.69%
Holding current value
$456,431
Previous $445,000 12.13%
% of portfolio
0.18%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $21,575 - $24,583
-135 Reduced 4.69%
2,741 $499,000
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $7,950 - $9,894
-60 Reduced 2.04%
2,876 $387,000
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $28,198 - $32,475
195 Added 7.11%
2,936 $467,000
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $220,623 - $297,864
2,741 New
2,741 $294,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ht Partners LLC Portfolio

Follow Ht Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ht Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ht Partners LLC with notifications on news.